INTRODUCTION: The Irish ALS register is a valuable resource for examining survival factors in Irish ALS patients. Cox regression has become the default tool for survival analysis, but recently new classes of flexible parametric survival analysis tools known as Royston-Parmar models have become available. METHODS: We employed Cox proportional hazards and Royston-Parmar flexible parametric modeling to examine factors affecting survival in Irish ALS patients. We further examined the effect of choice of timescale on Cox models and the proportional hazards assumption, and extended both Cox and Royston-Parmar models with time varying components. RESULTS: On comparison of models we chose a Royston-Parmar proportional hazards model without time var...
OBJECTIVE: To determine the long-term survival in amyotrophic lateral sclerosis (ALS) and identify...
Objective To determine the long-term survival in amyotrophic lateral sclerosis (ALS) and identify pr...
INTRODUCTION: ALS is a fatal neurodegenerative disease. However, patients show variability in the le...
The Irish ALS register is a valuable resource for examining survival factors in Irish ALS patients. ...
The natural history of amyotrophic lateral sclerosis (ALS) and patient risk stratification are areas...
International audienceThe natural history of amyotrophic lateral sclerosis (ALS) and patient risk st...
*<p>Possible ALS used as baseline category for El-Escorial category rate ratio calculations.</p>‡<p>...
Objective: To evaluate the survival of patients with amyotrophic lateral sclerosis (ALS) in an Itali...
<b><i>Objective:</i></b> To describe the clinical features at first evaluation that best predict sur...
Background: Amyotrophic lateral sclerosis (ALS) is a disease with a widely varying prognosis. The ma...
Amyotrophic lateral sclerosis is a progressive neurodegenerative disorder that leads to destruction ...
BACKGROUND: Although amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative ...
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a disease with a widely varying prognosis. The ma...
Objective: The heterogeneity of amyotrophic lateral sclerosis (ALS) survival duration, which varies ...
OBJECTIVE: To measure survivorship and predictors of prognosis of amyotrophic lateral sclerosis (ALS...
OBJECTIVE: To determine the long-term survival in amyotrophic lateral sclerosis (ALS) and identify...
Objective To determine the long-term survival in amyotrophic lateral sclerosis (ALS) and identify pr...
INTRODUCTION: ALS is a fatal neurodegenerative disease. However, patients show variability in the le...
The Irish ALS register is a valuable resource for examining survival factors in Irish ALS patients. ...
The natural history of amyotrophic lateral sclerosis (ALS) and patient risk stratification are areas...
International audienceThe natural history of amyotrophic lateral sclerosis (ALS) and patient risk st...
*<p>Possible ALS used as baseline category for El-Escorial category rate ratio calculations.</p>‡<p>...
Objective: To evaluate the survival of patients with amyotrophic lateral sclerosis (ALS) in an Itali...
<b><i>Objective:</i></b> To describe the clinical features at first evaluation that best predict sur...
Background: Amyotrophic lateral sclerosis (ALS) is a disease with a widely varying prognosis. The ma...
Amyotrophic lateral sclerosis is a progressive neurodegenerative disorder that leads to destruction ...
BACKGROUND: Although amyotrophic lateral sclerosis (ALS) is a rapidly progressive neurodegenerative ...
BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a disease with a widely varying prognosis. The ma...
Objective: The heterogeneity of amyotrophic lateral sclerosis (ALS) survival duration, which varies ...
OBJECTIVE: To measure survivorship and predictors of prognosis of amyotrophic lateral sclerosis (ALS...
OBJECTIVE: To determine the long-term survival in amyotrophic lateral sclerosis (ALS) and identify...
Objective To determine the long-term survival in amyotrophic lateral sclerosis (ALS) and identify pr...
INTRODUCTION: ALS is a fatal neurodegenerative disease. However, patients show variability in the le...